HSP90AA1 and neoplasm: With that in mind, the GOBO analysis revealed significantly reduced time of overall and relapse-free survival for patients with higher Hsp90α mRNA levels (Figure 6A and 6B), and therefore presumably Hsp90α protein levels, along with a correlation of significantly increased Hsp90α expression and higher tumor grade (Figure 6C).